TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Afya ( (AFYA) ) has issued an announcement.
On November 7, 2025, Afya Limited announced that the Ministry of Education’s Secretary of Regulation and Supervision of Higher Education authorized an increase of 100 medical seats at ITPAC Porto Nacional in Bragança, Pará. This expansion brings the total to 150 seats on this campus and 3,753 approved seats overall, reinforcing Afya’s commitment to quality medical education and its position as a leading medical education provider in Brazil.
The most recent analyst rating on (AFYA) stock is a Buy with a $25.50 price target. To see the full list of analyst forecasts on Afya stock, see the AFYA Stock Forecast page.
Spark’s Take on AFYA Stock
According to Spark, TipRanks’ AI Analyst, AFYA is a Outperform.
Afya’s strong financial performance and positive earnings call are the most significant factors driving the score. The company’s robust revenue growth, efficient cost management, and strategic initiatives like the share repurchase program highlight its potential for future growth. Technical analysis and valuation are supportive but less impactful, with the stock showing neutral momentum and reasonable valuation metrics.
To see Spark’s full report on AFYA stock, click here.
More about Afya
Afya is a leading medical education group in Brazil, providing a comprehensive ecosystem for medical students and professionals. The company offers a range of services from medical school education to residency preparation, continuing education, and medical practice solutions, empowering physicians throughout their careers.
Average Trading Volume: 101,324
Technical Sentiment Signal: Sell
Current Market Cap: $1.3B
Learn more about AFYA stock on TipRanks’ Stock Analysis page.